
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6051899
[patent_doc_number] => 20020170081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Transgenic mice containing GPR31 gene disruptions'
[patent_app_type] => new
[patent_app_number] => 10/109549
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24509
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20020170081.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109549 | Transgenic mice containing GPR31 gene disruptions | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6847683
[patent_doc_number] => 20030166850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Novel RGS9 protein binding interactions and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/108210
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 38951
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108210
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108210 | Novel RGS9 protein binding interactions and methods of use thereof | Mar 26, 2002 | Abandoned |
Array
(
[id] => 6798641
[patent_doc_number] => 20030177516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Gut-specific gene expression in transgenic avians'
[patent_app_type] => new
[patent_app_number] => 10/099663
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16964
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20030177516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099663 | Avian iFABP gene expression controlling region | Mar 13, 2002 | Issued |
Array
(
[id] => 5859056
[patent_doc_number] => 20020123107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Novel ABCA5 transporter and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/090458
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 31468
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090458 | Novel ABCA5 transporter and uses thereof | Feb 28, 2002 | Abandoned |
Array
(
[id] => 5844462
[patent_doc_number] => 20020132373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Immunoglobulin control region'
[patent_app_type] => new
[patent_app_number] => 10/081599
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10607
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081599 | Immunoglobulin control region | Feb 19, 2002 | Issued |
Array
(
[id] => 552308
[patent_doc_number] => 07160720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'CHAMP—a novel cardiac helicase-like factor'
[patent_app_type] => utility
[patent_app_number] => 10/077583
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 37505
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077583 | CHAMP—a novel cardiac helicase-like factor | Feb 14, 2002 | Issued |
Array
(
[id] => 6047648
[patent_doc_number] => 20020168660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Stem cell self-renewal and lineage commitment'
[patent_app_type] => new
[patent_app_number] => 10/077178
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8391
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077178 | Stem cell self-renewal and lineage commitment | Feb 14, 2002 | Abandoned |
Array
(
[id] => 5791842
[patent_doc_number] => 20020162128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Non-human animal deficient in function of pituitary adenylate cyclase-activating polypeptide gene'
[patent_app_type] => new
[patent_app_number] => 10/073135
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7775
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20020162128.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073135 | Non-human animal deficient in function of pituitary adenylate cyclase-activating polypeptide gene | Feb 12, 2002 | Abandoned |
Array
(
[id] => 7052713
[patent_doc_number] => 20050188432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes'
[patent_app_type] => utility
[patent_app_number] => 10/075105
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 9051
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20050188432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075105
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075105 | Bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes | Feb 12, 2002 | Issued |
Array
(
[id] => 5894785
[patent_doc_number] => 20060003324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Method for producing gene libraries'
[patent_app_type] => utility
[patent_app_number] => 10/468391
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5553
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468391 | Method for producing gene libraries | Feb 10, 2002 | Abandoned |
| 10/049407 | Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene | Feb 5, 2002 | Abandoned |
Array
(
[id] => 6990541
[patent_doc_number] => 20050089578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Methods and devices for tissue repair'
[patent_app_type] => utility
[patent_app_number] => 10/470946
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9768
[patent_no_of_claims] => 135
[patent_no_of_ind_claims] => 82
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470946 | Methods and devices for tissue repair | Feb 4, 2002 | Abandoned |
Array
(
[id] => 7220158
[patent_doc_number] => 20040072218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Methods and kits for identifying scavengers of reactive oxygen species (ros)'
[patent_app_type] => new
[patent_app_number] => 10/467104
[patent_app_country] => US
[patent_app_date] => 2003-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14970
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467104 | Methods and kits for identifying scavengers of reactive oxygen species (ROS) | Feb 4, 2002 | Issued |
Array
(
[id] => 5991152
[patent_doc_number] => 20020100071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Transgenic mouse with endogenous endoglin gene disruption'
[patent_app_type] => new
[patent_app_number] => 10/066949
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4835
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20020100071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10066949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/066949 | Transgenic mouse with endogenous endoglin gene disruption | Feb 3, 2002 | Abandoned |
Array
(
[id] => 5969135
[patent_doc_number] => 20020091146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Compositions and methods for treating glomerular disorders'
[patent_app_type] => new
[patent_app_number] => 10/059763
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6698
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091146.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059763
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059763 | Compositions and methods for treating glomerular disorders | Jan 28, 2002 | Abandoned |
Array
(
[id] => 6654192
[patent_doc_number] => 20030077288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Compositions and methods for treatment of muscle wasting'
[patent_app_type] => new
[patent_app_number] => 10/050686
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 36294
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050686
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050686 | Compositions and methods for treatment of muscle wasting | Jan 15, 2002 | Abandoned |
Array
(
[id] => 6560590
[patent_doc_number] => 20020164705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => '39362, a novel human CUB domain-containing protein family member and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/041406
[patent_app_country] => US
[patent_app_date] => 2002-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 50397
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164705.pdf
[firstpage_image] =>[orig_patent_app_number] => 10041406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/041406 | 39362, a novel human CUB domain-containing protein family member and uses thereof | Jan 7, 2002 | Abandoned |
| 09/890405 | Inducible expression system for use in plants | Dec 30, 2001 | Abandoned |
Array
(
[id] => 6083080
[patent_doc_number] => 20020082416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Method for obtaining DNA from fish spermatogonium'
[patent_app_type] => new
[patent_app_number] => 10/029281
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3590
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082416.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029281 | Method for obtaining DNA from fish spermatogonium | Dec 27, 2001 | Issued |
Array
(
[id] => 6559919
[patent_doc_number] => 20020164666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Protein-protein interactions'
[patent_app_type] => new
[patent_app_number] => 10/023446
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10505
[patent_no_of_claims] => 160
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023446
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023446 | Protein-protein interactions | Dec 19, 2001 | Abandoned |